We're excited to share that data from NyquistAI has been leveraged in a newly published paper in npj Digital Medicine: Two decades of growth and trends in the FDA authorization of digital medical devices.
The study analyzes more than twenty years of FDA authorizations for digital medical devices, providing one of the most comprehensive views to date of how the field has evolved. By examining trends across device categories, regulatory pathways, and technological advances, the authors offer valuable insights into the maturation of digital medicine and the future direction of medical AI and software-based healthcare technologies.
We're proud that the researchers chose to leverage NyquistAI's structured FDA medical device intelligence to support their analysis. Our mission has always been to make complex regulatory data accessible, searchable, and research-ready. It's rewarding to see that data contribute to peer-reviewed research published in one of the leading journals in digital health.
This collaboration reflects the growing role of high-quality regulatory datasets in advancing evidence-based research, informing policy, and helping innovators better understand the rapidly evolving medical device landscape.
Congratulations to the authors on this excellent publication. We're honored that NyquistAI could play a small part in supporting their work, and we look forward to enabling many more impactful research efforts in the future.